Glossary for Health Technology Lifecycle by EuroScan - User contributions [en]

http://glossary.i-hts.org/api.php?action=feedcontributions&feedformat=atom&user=Admin1 Glossary for Health Technology Lifecycle by EuroScan - User contributions [en] 2026-10-17T02:12:58Z User contributions MediaWiki 1.40.1 http://glossary.i-hts.org/index.php?title=Signal&diff=960 Signal 2026-06-07T03:07:46Z

<p>Admin1: Created page with "A signal is an observable, patterned change in a medium, behavior or attribute that can be distinguished from background variation and interpreted by a receiver as information about an underlying state or characteristic. In social and economic contexts, signals are often deliberately or strategically produced under conditions of information asymmetry, with their credibility grounded in costs, constraints, or shared social norms that make them harder for some actors to mi..."</p> <hr /> <div>A signal is an observable, patterned change in a medium, behavior or attribute that can be distinguished from background variation and interpreted by a receiver as information about an underlying state or characteristic. In social and economic contexts, signals are often deliberately or strategically produced under conditions of information asymmetry, with their credibility grounded in costs, constraints, or shared social norms that make them harder for some actors to mimic than others.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=958 Welcome 2026-01-27T13:51:08Z

<p>Admin1: </p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:6px 10px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:6px 10px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div><div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;"><div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> by EuroScan international network eV<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Re-Assessment (Re-HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early awareness and alert system]]<br /> <br /> Early Awareness is a context sensitive framework including the service for different stakeholders and describing their needs relted to innovations in health.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div></div><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<div><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Re-Assessment worldwide.<br /> </div><div><br /> [http://glossary.i-hts.org/My_wiki:Privacy_policy Privacy policy] &nbsp;•&nbsp; [http://glossary.i-hts.org/My_wiki:About Imprint / Contact]<br /> </div></div><br /> <br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=957 Welcome 2026-01-27T13:49:14Z

<p>Admin1: </p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:6px 10px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:6px 10px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div><div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;"><div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> by EuroScan international network eV<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Re-Assessment (Re-HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early awareness and alert system]]<br /> <br /> Early Awareness is a context sensitive framework including the service for different stakeholders and describing their needs relted to innovations in health.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div></div><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<div><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Re-Assessment worldwide.<br /> </div><div><br /> [http://glossary.i-hts.org/My_wiki:Privacy_policy Privacy policy] &nbsp;•&nbsp; [http://glossary.i-hts.org/My_wiki:About Imprint / Contact]<br /> </div></div><br /> <br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=956 Welcome 2026-01-27T13:39:42Z

<p>Admin1: </p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:8px 16px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:8px 16px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div><div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;"><div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> by EuroScan international network eV<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Re-Assessment (Re-HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early awareness and alert system]]<br /> <br /> Early Awareness is a context sensitive framework including the service for different stakeholders and describing their needs relted to innovations in health.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div></div><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<div><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Re-Assessment worldwide.<br /> </div><div><br /> [http://glossary.i-hts.org/My_wiki:Privacy_policy Privacy policy] &nbsp;•&nbsp; [http://glossary.i-hts.org/My_wiki:About Imprint / Contact]<br /> </div></div><br /> <br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=955 Welcome 2026-01-27T13:37:28Z

<p>Admin1: </p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:8px 16px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:8px 16px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div><div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;"><div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> by EuroScan international network eV<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Re-Assessment (Re-HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early Awareness|Early Health Technology Assessment (early HTA)]]<br /> <br /> Early Awareness is a context sensitive framework including the service for different stakeholders and describing their needs relted to innovations in health.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div></div><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<div><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Re-Assessment worldwide.<br /> </div><div><br /> [http://glossary.i-hts.org/My_wiki:Privacy_policy Privacy policy] &nbsp;•&nbsp; [http://glossary.i-hts.org/My_wiki:About Imprint / Contact]<br /> </div></div><br /> <br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=My_wiki:About&diff=954 My wiki:About 2026-01-27T13:34:46Z

<p>Admin1: </p> <hr /> <div>= About the i‑HTS Glossary for the Health Technology Lifecycle =<br /> <br /> The i‑HTS Glossary is a collaborative, curated resource that explains<br /> terms and concepts used along the entire lifecycle of health<br /> technologies – from early awareness and horizon scanning to assessment,<br /> implementation, re‑assessment and disinvestment.[[Main Page| ]]<br /> <br /> It is developed within the international HealthTechScan (i‑HTS)<br /> network, which grew out of the EuroScan international network, and<br /> supports a shared vocabulary for Early Awareness and Health Technology<br /> Assessment (HTA) worldwide.<br /> <br /> __TOC__<br /> <br /> == Who is behind this glossary? ==<br /> <br /> The glossary is hosted and maintained by the international<br /> HealthTechScan (i‑HTS) network, the global brand for the EuroScan<br /> international scientific association and its services.<br /> <br /> i‑HTS brings together organisations and experts involved in:<br /> <br /> * Horizon scanning and early awareness & alert (EAA) systems<br /> * Health Technology Assessment (HTA)<br /> * Disinvestment and obsolete technologies<br /> * Policy making, health system management and health services research[web:135][web:156][web:157]<br /> <br /> Members and partners contribute terms, definitions and use cases to<br /> ensure that the glossary reflects current practice and scientific<br /> standards in Early Awareness and HTA.<br /> <br /> == Purpose of the glossary ==<br /> <br /> The main purposes of the glossary are:<br /> <br /> * To provide clear, concise definitions of key terms in the<br /> health technology lifecycle, with references to recognised<br /> sources (guidelines, scientific publications, policy documents).[web:142][web:153]<br /> * To harmonise wording and meaning across scientific communities,<br /> HTA agencies, decision makers and educators.<br /> * To support communication and capacity building in horizon<br /> scanning, early awareness, assessment and disinvestment activities.[web:135][web:155]<br /> * To serve as a reference point for methodological work on Early<br /> HTA and related concepts (early dialogue, early advice, etc.).[web:153][web:155]<br /> <br /> The glossary is openly accessible so that researchers, policymakers,<br /> clinicians, students and the interested public can benefit from a<br /> shared language.<br /> <br /> == What is covered? ==<br /> <br /> The glossary currently includes (or aims to include) terms in areas such as:<br /> <br /> * **Health technologies** – including medicines, devices, diagnostics,<br /> procedures, programmes and organisational interventions.<br /> * **Lifecycle stages** – from identification of emerging technologies<br /> to routine use and possible disinvestment.<br /> * **Methods and processes** – horizon scanning, early awareness, health for all policies,<br /> reassessment, economic evaluation, stakeholder engagement and more.<br /> * **Policy and system terms** – reimbursement, coverage decisions,<br /> benefit packages, priority setting and related concepts.<br /> <br /> New topics are added as the network’s work evolves.<br /> <br /> == How are terms created and maintained? ==<br /> <br /> The glossary is a curated wiki based on the MediaWiki software. Terms<br /> are not freely editable by anonymous users but are maintained by<br /> registered contributors within the i‑HTS / EuroScan community.<br /> <br /> Key features of the editorial process:<br /> <br /> * **Registered contributors** draft entries using a common structure<br /> (definition, context, related terms, references).<br /> * **Editors and working groups** review definitions, check references<br /> and ensure consistency with existing terminology and HTA standards.<br /> * **Version history** – all changes are tracked and can be reviewed<br /> via the page history and the [[Special:RecentChanges|Recent changes]]<br /> page.<br /> * **Discussion and refinement** – for complex or evolving concepts,<br /> the talk pages are used to document alternative views and<br /> reasoning.<br /> <br /> For practical guidance on adding or editing terms, see:<br /> [[My_wiki:How_to_add_terms|How to add terms to this glossary]].<br /> <br /> == Who can contribute? ==<br /> <br /> At present, the glossary is primarily edited by:<br /> <br /> * Members of the EuroScan / i‑HTS network<br /> * Collaborating HTA agencies and research groups<br /> * Invited experts working on Early Awareness and HTA/HTM terminology<br /> <br /> If you would like to contribute:<br /> <br /> # Visit [[My_wiki:How_to_add_terms|How to add terms to this glossary]].<br /> # Contact the i‑HTS office at '''office@i-hts.org''' to request an<br /> editor account or to propose new terms and definitions.<br /> <br /> Contributions are expected to be evidence‑based and referenced, drawing<br /> on recognised guidelines and peer‑reviewed literature wherever<br /> possible.<br /> <br /> == Use and citation ==<br /> <br /> You are welcome to use the glossary for teaching, research and<br /> policy work. When referring to definitions from this glossary, please:<br /> <br /> * Link to the specific term page on glossary.i‑hts.org, and<br /> * Where appropriate, cite the original sources listed under<br /> “References” in the term entry.<br /> <br /> The glossary aims to complement, not replace, existing HTA glossaries<br /> and international terminology resources. It focuses in particular on<br /> terms that are important for Early Awareness, horizon scanning and Re-Assessment.<br /> <br /> == Contact and further information ==<br /> <br /> For questions about the glossary or the i‑HTS network:<br /> <br /> * Visit the i‑HTS website:<br /> [https://ihts.org the international HealthTechScan (i‑HTS) website]<br /> * Learn more about the glossary:<br /> [https://ihts.org/the-glossary-for-early-awareness-and-hta/ The glossary for the Health Technology Lifecycle]<br /> * Email: '''office@i-hts.org''' (general enquiries, collaboration,<br /> account requests).<br /> <br /> If you have suggestions to improve this “About” page, please use<br /> the associated talk page or contact the coordination team.</div>

Admin1 http://glossary.i-hts.org/index.php?title=My_wiki:About&diff=953 My wiki:About 2026-01-27T13:32:14Z

<p>Admin1: </p> <hr /> <div>= About the i‑HTS Glossary for the Health Technology Lifecycle =<br /> <br /> The i‑HTS Glossary is a collaborative, curated resource that explains<br /> terms and concepts used along the entire lifecycle of health<br /> technologies – from early awareness and horizon scanning to assessment,<br /> implementation, re‑assessment and disinvestment.[[Main Page| ]] [web:115][web:142]<br /> <br /> It is developed within the international HealthTechScan (i‑HTS)<br /> network, which grew out of the EuroScan international network, and<br /> supports a shared vocabulary for Early Awareness and Health Technology<br /> Assessment (HTA) worldwide.[web:139][web:154][web:157]<br /> <br /> __TOC__<br /> <br /> == Who is behind this glossary? ==<br /> <br /> The glossary is hosted and maintained by the international<br /> HealthTechScan (i‑HTS) network, the global brand for the EuroScan<br /> international scientific association and its services.[web:139][web:154]<br /> <br /> i‑HTS brings together organisations and experts involved in:<br /> <br /> * Horizon scanning and early awareness & alert (EAA) systems<br /> * Health Technology Assessment (HTA)<br /> * Disinvestment and obsolete technologies<br /> * Policy making, health system management and health services research[web:135][web:156][web:157]<br /> <br /> Members and partners contribute terms, definitions and use cases to<br /> ensure that the glossary reflects current practice and scientific<br /> standards in Early Awareness and HTA.[web:142][web:150]<br /> <br /> == Purpose of the glossary ==<br /> <br /> The main purposes of the glossary are:<br /> <br /> * To provide clear, concise definitions of key terms in the<br /> health technology lifecycle, with references to recognised<br /> sources (guidelines, scientific publications, policy documents).[web:142][web:153]<br /> * To harmonise wording and meaning across scientific communities,<br /> HTA agencies, decision makers and educators.<br /> * To support communication and capacity building in horizon<br /> scanning, early awareness, assessment and disinvestment activities.[web:135][web:155]<br /> * To serve as a reference point for methodological work on Early<br /> HTA and related concepts (early dialogue, early advice, etc.).[web:153][web:155]<br /> <br /> The glossary is openly accessible so that researchers, policymakers,<br /> clinicians, students and the interested public can benefit from a<br /> shared language.<br /> <br /> == What is covered? ==<br /> <br /> The glossary currently includes (or aims to include) terms in areas such as:<br /> <br /> * **Health technologies** – including medicines, devices, diagnostics,<br /> procedures, programmes and organisational interventions.[web:117][web:153]<br /> * **Lifecycle stages** – from identification of emerging technologies<br /> to routine use and possible disinvestment.[web:135][web:156]<br /> * **Methods and processes** – horizon scanning, early awareness, health for all policies,<br /> reassessment, economic evaluation, stakeholder engagement and more.[web:135][web:150][web:155]<br /> * **Policy and system terms** – reimbursement, coverage decisions,<br /> benefit packages, priority setting and related concepts.[web:135][web:157]<br /> <br /> New topics are added as the network’s work evolves.<br /> <br /> == How are terms created and maintained? ==<br /> <br /> The glossary is a curated wiki based on the MediaWiki software. Terms<br /> are not freely editable by anonymous users but are maintained by<br /> registered contributors within the i‑HTS / EuroScan community.[web:116][web:148]<br /> <br /> Key features of the editorial process:<br /> <br /> * **Registered contributors** draft entries using a common structure<br /> (definition, context, related terms, references).<br /> * **Editors and working groups** review definitions, check references<br /> and ensure consistency with existing terminology and HTA standards.[web:142][web:155]<br /> * **Version history** – all changes are tracked and can be reviewed<br /> via the page history and the [[Special:RecentChanges|Recent changes]]<br /> page.<br /> * **Discussion and refinement** – for complex or evolving concepts,<br /> the talk pages are used to document alternative views and<br /> reasoning.<br /> <br /> For practical guidance on adding or editing terms, see:<br /> [[My_wiki:How_to_add_terms|How to add terms to this glossary]].<br /> <br /> == Who can contribute? ==<br /> <br /> At present, the glossary is primarily edited by:<br /> <br /> * Members of the EuroScan / i‑HTS network<br /> * Collaborating HTA agencies and research groups<br /> * Invited experts working on Early Awareness and HTA/HTM terminology[web:139][web:155]<br /> <br /> If you would like to contribute:<br /> <br /> # Visit [[My_wiki:How_to_add_terms|How to add terms to this glossary]].<br /> # Contact the i‑HTS office at '''office@i-hts.org''' to request an<br /> editor account or to propose new terms and definitions.[web:139][web:142]<br /> <br /> Contributions are expected to be evidence‑based and referenced, drawing<br /> on recognised guidelines and peer‑reviewed literature wherever<br /> possible.[web:142][web:153][web:150]<br /> <br /> == Use and citation ==<br /> <br /> You are welcome to use the glossary for teaching, research and<br /> policy work. When referring to definitions from this glossary, please:<br /> <br /> * Link to the specific term page on glossary.i‑hts.org, and<br /> * Where appropriate, cite the original sources listed under<br /> “References” in the term entry.<br /> <br /> The glossary aims to complement, not replace, existing HTA glossaries<br /> and international terminology resources. It focuses in particular on<br /> terms that are important for Early Awareness, horizon scanning and Re-Assessment.[web:142][web:153][web:156]<br /> <br /> == Contact and further information ==<br /> <br /> For questions about the glossary or the i‑HTS network:<br /> <br /> * Visit the i‑HTS website:<br /> [https://ihts.org the international HealthTechScan (i‑HTS) website][web:130][web:139]<br /> * Learn more about the glossary:<br /> [https://ihts.org/the-glossary-for-early-awareness-and-hta/ The glossary for the Health Technology Lifecycle][web:142]<br /> * Email: '''office@i-hts.org''' (general enquiries, collaboration,<br /> account requests).[web:139]<br /> <br /> If you have suggestions to improve this “About” page, please use<br /> the associated talk page or contact the coordination team.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=952 Welcome 2026-01-27T13:21:27Z

<p>Admin1: </p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:8px 16px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:8px 16px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div><div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;"><div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> by EuroScan international network eV<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Re-Assessment (Re-HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early HTA|Early Health Technology Assessment (early HTA)]]<br /> <br /> Early HTA supports decision-making on promising technologies before large-scale implementation and helps to prioritise further research.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div></div><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<div><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Re-Assessment worldwide.<br /> </div><div><br /> [http://glossary.i-hts.org/My_wiki:Privacy_policy Privacy policy] &nbsp;•&nbsp; [http://glossary.i-hts.org/My_wiki:About Imprint / Contact]<br /> </div></div><br /> <br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=951 Welcome 2026-01-27T13:21:02Z

<p>Admin1: </p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:8px 16px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:8px 16px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div><div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;"><div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> by EuroScan international network eV<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Assessment (HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early HTA|Early Health Technology Assessment (early HTA)]]<br /> <br /> Early HTA supports decision-making on promising technologies before large-scale implementation and helps to prioritise further research.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div></div><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<div><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Re-Assessment worldwide.<br /> </div><div><br /> [http://glossary.i-hts.org/My_wiki:Privacy_policy Privacy policy] &nbsp;•&nbsp; [http://glossary.i-hts.org/My_wiki:About Imprint / Contact]<br /> </div></div><br /> <br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=950 Welcome 2026-01-27T13:20:22Z

<p>Admin1: </p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:8px 16px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:8px 16px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div><div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;">[[Index.php?title=File:IHTS-logo.png|center|alt=international HealthTechScan (i‑HTS) logo|200x200px]]<div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Assessment (HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early HTA|Early Health Technology Assessment (early HTA)]]<br /> <br /> Early HTA supports decision-making on promising technologies before large-scale implementation and helps to prioritise further research.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div></div><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<div><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Re-Assessment worldwide.<br /> </div><div><br /> [http://glossary.i-hts.org/My_wiki:Privacy_policy Privacy policy] &nbsp;•&nbsp; [http://glossary.i-hts.org/My_wiki:About Imprint / Contact]<br /> </div></div><br /> <br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=949 Welcome 2026-01-27T13:19:49Z

<p>Admin1: /* Welcome to the i‑HTS Glossary for the Health Technology Lifecycle */</p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:8px 16px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:8px 16px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div><div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;">[[index.php?title=File:IHTS-logo.png|center|alt=international HealthTechScan (i‑HTS) logo|200x200px]]<div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Assessment (HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early HTA|Early Health Technology Assessment (early HTA)]]<br /> <br /> Early HTA supports decision-making on promising technologies before large-scale implementation and helps to prioritise further research.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div><div style="margin:24px 0 12px 0; padding:12px 16px; border-top:1px solid #d0dde8; font-size:0.9em; color:#555;"><div style="display:flex; flex-wrap:wrap; gap:12px; align-items:center; justify-content:space-between;"><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Assessment worldwide.<br /> </div><div><br /> [[My wiki:Privacy policy|Privacy policy]] &nbsp;•&nbsp; [[My wiki:About|Imprint / Contact]]<br /> </div></div></div></div><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<div><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Re-Assessment worldwide.<br /> </div><div><br /> [http://glossary.i-hts.org/My_wiki:Privacy_policy Privacy policy] &nbsp;•&nbsp; [http://glossary.i-hts.org/My_wiki:About Imprint / Contact]<br /> </div></div><br /> <br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=948 Welcome 2026-01-27T13:17:30Z

<p>Admin1: </p> <hr /> <div><div><div><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div><br /> [http://glossary.i-hts.org/Special:AllPages <br /> '''<br /> Browse all terms<br /> ''']<br /> &nbsp;<br /> [http://glossary.i-hts.org/My_wiki:About <br /> <br /> About EuroScan / i‑HTS]<br /> </div></div><div><div><div><br /> international HealthTechScan (i‑HTS)<br /> <br /> by EuroScan international network eV<br /> </div><div><br /> A global network supporting Early Awareness and Health Technology<br /> Re-Assessment (Re-HTA) through a shared vocabulary.<br /> </div></div></div></div><div><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [http://glossary.i-hts.org/Special:AllPages All terms (A–Z)]<br /> *<br /> *<br /> *<br /> *<br /> </div><div><div><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [http://glossary.i-hts.org/Early_HTA Early Health Technology Assessment (early HTA)]<br /> <br /> Early HTA supports decision-making on promising technologies before large-scale implementation and helps to prioritise further research.<br /> </div><div><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [http://glossary.i-hts.org/My_wiki:About Read about goals and scope]<br /> * [http://glossary.i-hts.org/Help:Contents Help for editing pages]<br /> * [http://glossary.i-hts.org/Special:RecentChanges Recent changes in the glossary]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div><div></div><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<div><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Re-Assessment worldwide.<br /> </div><div><br /> [http://glossary.i-hts.org/My_wiki:Privacy_policy Privacy policy] &nbsp;•&nbsp; [http://glossary.i-hts.org/My_wiki:About Imprint / Contact]<br /> </div></div><br /> <br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Testseite_welcome&diff=947 Testseite welcome 2026-01-27T13:14:24Z

<p>Admin1: </p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:8px 16px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:8px 16px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div> <div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;"><div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> <br /> by EuroScan international network eV<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Re-Assessment (Re-HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early HTA|Early Health Technology Assessment (early HTA)]]<br /> <br /> Early HTA supports decision-making on promising technologies before large-scale implementation and helps to prioritise further research.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div><div style="margin:24px 0 12px 0; padding:12px 16px; border-top:1px solid #d0dde8; font-size:0.9em; color:#555;"><div style="display:flex; flex-wrap:wrap; gap:12px; align-items:center; justify-content:space-between;"><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Assessment worldwide.<br /> </div><div><br /> [[My wiki:Privacy policy|Privacy policy]] &nbsp;•&nbsp; [[My wiki:About|Imprint / Contact]]<br /> </div></div></div></div></div>

Admin1 http://glossary.i-hts.org/index.php?title=Testseite_welcome&diff=946 Testseite welcome 2026-01-27T13:13:49Z

<p>Admin1: </p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:8px 16px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:8px 16px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div> international HealthTechScan (i‑HTS)<div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;"><div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> by EuroScan international network eV<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Re-Assessment (Re-HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early HTA|Early Health Technology Assessment (early HTA)]]<br /> <br /> Early HTA supports decision-making on promising technologies before large-scale implementation and helps to prioritise further research.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div><div style="margin:24px 0 12px 0; padding:12px 16px; border-top:1px solid #d0dde8; font-size:0.9em; color:#555;"><div style="display:flex; flex-wrap:wrap; gap:12px; align-items:center; justify-content:space-between;"><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Assessment worldwide.<br /> </div><div><br /> [[My wiki:Privacy policy|Privacy policy]] &nbsp;•&nbsp; [[My wiki:About|Imprint / Contact]]<br /> </div></div></div></div></div>

Admin1 http://glossary.i-hts.org/index.php?title=Help:Contents&diff=945 Help:Contents 2026-01-27T13:10:46Z

<p>Admin1: Created page with "= How to add terms to the i‑HTS Glossary = This page explains how members of the EuroScan / i‑HTS community can propose and edit terms in the glossary at glossary.i-hts.org. == 1. Who can contribute? == The glossary is a curated resource. To keep the quality of definitions high, editing rights are reserved for registered users who are part of the EuroScan / i‑HTS community or collaborating organisations.[web:115][web:142] There are three main role..."</p> <hr /> <div>= How to add terms to the i‑HTS Glossary =<br /> <br /> This page explains how members of the EuroScan / i‑HTS community can<br /> propose and edit terms in the glossary at [[Main Page|glossary.i-hts.org]].<br /> <br /> == 1. Who can contribute? ==<br /> <br /> The glossary is a curated resource. To keep the quality of definitions<br /> high, editing rights are reserved for registered users who are part of<br /> the EuroScan / i‑HTS community or collaborating organisations.[web:115][web:142]<br /> <br /> There are three main roles:<br /> <br /> * '''Readers''' – Everyone can read and search the glossary without<br /> an account.<br /> * '''Registered contributors''' – Can create and edit glossary entries,<br /> following the editorial guidelines.<br /> * '''Editors / administrators''' – Review changes, harmonise<br /> definitions and manage user rights.<br /> <br /> If you would like to become a contributor, please see the registration<br /> process below.<br /> <br /> == 2. Registration and access ==<br /> <br /> To obtain an account with editing rights, follow these steps:<br /> <br /> # Go to the glossary homepage: [https://glossary.i-hts.org glossary.i-hts.org].<br /> # Click on '''Create account''' (top right of the page). If self‑registration<br /> is not open, please use the contact op</div>

Admin1 http://glossary.i-hts.org/index.php?title=Testseite_welcome&diff=944 Testseite welcome 2026-01-27T13:07:38Z

<p>Admin1: Created page with "<div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle = This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health tech..."</p> <hr /> <div><div style="max-width:1100px; margin:0 auto;"><div style="display:flex; flex-wrap:wrap; align-items:center; gap:24px; margin:24px 0;"><div style="flex:1 1 320px; min-width:280px;"><br /> = Welcome to the i‑HTS Glossary for the Health Technology Lifecycle =<br /> This glossary is an initiative of the EuroScan/i‑HTS network and collects terms, concepts and definitions used along the entire lifecycle of health technologies – from early development and assessment to implementation, use and disinvestment.<br /> <br /> It supports a shared language for researchers, HTA bodies, policy makers, clinicians, educators and the public, helping to improve communication and collaboration across countries and disciplines.<div style="margin-top:16px;"><br /> [[Special:AllPages|<br /> <span style="display:inline-block; background:#0088aa; color:#fff; padding:8px 16px; border-radius:4px; font-weight:bold;"><br /> Browse all terms<br /> </span>]]<br /> &nbsp;<br /> [[My wiki:About|<br /> <span style="display:inline-block; padding:8px 16px; border-radius:4px; border:1px solid #0088aa; color:#0088aa;"><br /> About EuroScan / i‑HTS<br /> </span>]]<br /> </div></div><div style="flex:0 1 280px; min-width:240px; text-align:center;"><div style="background:#f3f8fb; border:1px solid #d0e0ec; border-radius:8px; padding:18px 12px;">[[index.php?title=File:IHTS-logo.png|center|alt=international HealthTechScan (i‑HTS) logo|200x200px]]<div style="margin-top:10px; font-weight:bold; color:#005b8f; font-size:1.0em;"><br /> international HealthTechScan (i‑HTS)<br /> </div><div style="font-size:0.9em; color:#345;"><br /> A global network supporting Early Awareness and Health Technology<br /> Assessment (HTA) through a shared vocabulary.<br /> </div></div></div></div><div style="margin:24px 0; padding:16px 18px; background:#f5fafc; border:1px solid #d7e6f0; border-radius:6px;"><br /> == Find terms quickly ==<br /> Use the search box at the top of the page to look up specific terms. You can also explore terms alphabetically or by topic:<br /> <br /> * [[Special:AllPages|All terms (A–Z)]]<br /> *<br /> *<br /> *<br /> *<br /> </div><div style="display:flex; flex-wrap:wrap; gap:24px; margin:24px 0;"><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Key concept of the month ===<br /> Learn more about how technologies are assessed in an early phase:<br /> <br /> &#x27A4; [[Early HTA|Early Health Technology Assessment (early HTA)]]<br /> <br /> Early HTA supports decision-making on promising technologies before large-scale implementation and helps to prioritise further research.<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Explore by lifecycle stage ===<br /> The glossary follows the lifecycle of health technologies. Start exploring terms for:<br /> <br /> * Development and early awareness<br /> * Regulatory approval and market access<br /> * Implementation and real‑world use<br /> * Re‑assessment and disinvestment<br /> </div><div style="flex:1 1 260px; min-width:240px; background:#ffffff; border:1px solid #dde6f0; border-radius:6px; padding:14px 16px;"><br /> === Contribute to this glossary ===<br /> Members of the EuroScan/i‑HTS community can propose new terms or improve existing definitions, referencing scientific and policy documents.<br /> <br /> * [[My wiki:About|Read about goals and scope]]<br /> * [[Help:Contents|Help for editing pages]]<br /> * [[Special:RecentChanges|Recent changes in the glossary]]<br /> * [https://ihts.org/the-glossary-for-early-awareness-and-hta/ Learn more on i‑HTS.org]<br /> </div></div><div style="margin:24px 0 12px 0; padding:12px 16px; border-top:1px solid #d0dde8; font-size:0.9em; color:#555;"><div style="display:flex; flex-wrap:wrap; gap:12px; align-items:center; justify-content:space-between;"><div><br /> Part of the EuroScan international network – supporting Early Awareness<br /> and Health Technology Assessment worldwide.<br /> </div><div><br /> [[My wiki:Privacy policy|Privacy policy]] &nbsp;•&nbsp; [[My wiki:About|Imprint / Contact]]<br /> </div></div></div></div></div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=943 Welcome 2026-01-27T12:40:58Z

<p>Admin1: </p> <hr /> <div>= Welcome to the glossary and wiki for terminologies in life-cycle of health technologies =<br /> <br /> == Topics ==<br /> <br /> * terms, concepts and terminologies used in the health arena for innovations, demands, research, developments, appropriate usage and disinvestment.<br /> * there is no intention to define terms, but to describe and clarify meanings of concepts and frameworks across the different scientific and handling areas of technologies (pharmaceuticals, medical devices and software (incl. digital Tools and AI), and health care procedures). Achieving a better understanding betwenn specifications and supporting harmonization within a specific domain.<br /> * tools and their description in the area of Early Awareness / Re-Assessment (including the process of Horizon Scanning / Disinvestment), Health Technology Assessment (HTA) and Health for all policies (HFAP) including Needs and Demands<br /> <br /> == Resources ==<br /> We are searching and integrating not only the opinion of our own network but include also freely available terms of other global networks and specialised organisations.<br /> <br /> == Participate ==<br /> Be part of the community and join discussions, or even more, be part of the editors community to validate and publish terms<br /> <br /> <big>Register or get in touch with our office: [mailto:Office@i-hts.org office@i-hts.org]</big><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=My_wiki:Privacy_policy&diff=942 My wiki:Privacy policy 2025-12-16T08:35:10Z

<p>Admin1: </p> <hr /> <div>Datenschutzerklärung für glossary.i-hts.org<br /> <br /> Stand: 16. Dezember 2025<br /> <br /> 1.Verantwortliche Stelle<br /> <br /> Verantwortlich im Sinne der Datenschutz-Grundverordnung (DSGVO) und anderer nationaler Datenschutzgesetze der Mitgliedsstaaten sowie sonstiger datenschutzrechtlicher Bestimmungen ist:<br /> <br /> EuroScan international network e.V.<br /> (Verein eingetragen in Deutschland)<br /> E-Mail: office@i-hts.org<br /> Website: glossary.i-hts.org<br /> <br /> 2.Geltungsbereich<br /> <br /> Diese Datenschutzerklärung gilt für das Informationsangebot unter der Domain glossary.i-hts.org.<br /> <br /> 3.Datenerfassung und -verarbeitung beim Besuch der Website<br /> <br /> 3.1. Server-Logfiles<br /> Beim bloßen Besuch der Website werden durch den auf Ihrem Endgerät zum Einsatz kommenden Browser automatisch Informationen an den Server der Website gesendet und temporär in sogenannten **Server-Logfiles** gespeichert. Dies sind:<br /> <br /> * Browsertyp und Browserversion<br /> * Verwendetes Betriebssystem<br /> * Referrer URL (die zuvor besuchte Seite)<br /> * Hostname des zugreifenden Rechners (IP-Adresse)<br /> * Uhrzeit der Serveranfrage<br /> <br /> Diese Daten dienen zur Sicherstellung eines reibungslosen Verbindungsaufbaus und einer komfortablen Nutzung unserer Website. Die Rechtsgrundlage für die Verarbeitung ist Art. 6 Abs. 1 lit. f DSGVO (berechtigtes Interesse an der technischen Funktionsfähigkeit der Website).<br /> <br /> 3.2. Cookies<br /> Unsere MediaWiki-Installation verwendet **Cookies**. Hierbei handelt es sich um kleine Textdateien, die auf Ihrem Endgerät gespeichert werden. Wir verwenden temporäre (Session-)Cookies, um die Navigation zu erleichtern und die Sicherheit zu gewährleisten. Diese Cookies werden nach Ende Ihres Besuchs automatisch gelöscht.<br /> <br /> Rechtsgrundlage: Art. 6 Abs. 1 lit. f DSGVO.<br /> <br /> 4.Datenverarbeitung bei der Registrierung (Persönliche Daten)<br /> <br /> 4.1. Art und Zweck der Daten<br /> Um als Autor oder Bearbeiter auf glossary.i-hts.org aktiv werden zu können, ist eine Registrierung erforderlich. Im Rahmen dieser Registrierung speichern wir folgende personenbezogene Daten (Pflichtangaben):<br /> <br /> Benutzername (öffentlich sichtbar)<br /> E-Mail-Adresse (nicht öffentlich sichtbar, wird zur Kommunikation und zur Passwortwiederherstellung verwendet)<br /> Passwort (verschlüsselt)<br /> <br /> Der Zweck der Speicherung dieser Daten ist die **Authentifizierung** und Autorisierung von Nutzern zur Beitragsleistung im Wiki sowie zur Sicherstellung der Nachvollziehbarkeit von Bearbeitungen (Art. 6 Abs. 1 lit. b DSGVO, Erfüllung des Nutzungsvertrages).<br /> <br /> 4.2. Nachvollziehbarkeit von Beiträgen<br /> Alle von registrierten Nutzern getätigten Bearbeitungen und Beiträge (inklusive der IP-Adresse zum Zeitpunkt der Bearbeitung) werden dauerhaft gespeichert und sind unter dem verwendeten Benutzername in der Versionsgeschichte der jeweiligen Seite öffentlich einsehbar. Dies dient der Transparenz und Qualitätssicherung.<br /> <br /> 5.Ihre Rechte als Betroffene(r)<br /> <br /> Sie haben das Recht auf Auskunft, Berichtigung, Löschung, Einschränkung der Verarbeitung, Widerspruch gegen die Verarbeitung sowie auf Datenübertragbarkeit.<br /> <br /> 5.1. Auskunft und Löschung (Betroffenenrechte)<br /> Da die technischen Möglichkeiten zur direkten Nutzerverwaltung auf dieser MediaWiki-Instanz begrenzt sind, bitten wir Sie, alle Anfragen bezüglich Ihrer Betroffenenrechte (insbesondere Auskunft über Ihre gespeicherten Daten und Löschung Ihres Accounts und der damit verbundenen persönlichen Daten) ausschließlich an unser Sekretariat zu richten:<br /> <br /> E-Mail: office@i-hts.org<br /> <br /> Das Sekretariat wird Ihre Anfrage bearbeiten und die notwendigen Schritte zur Erfüllung Ihrer Rechte einleiten.<br /> <br /> Achtung: Eine Löschung des Accounts erfolgt durch das Sekretariat. Beiträge, die Sie vor der Löschung geleistet haben, bleiben in der Versionsgeschichte der Seiten erhalten, werden jedoch Möglichkeit anonymisiert oder unter einem neutralen Benutzernamen geführt, soweit dies technisch und rechtlich möglich ist.<br /> <br /> 5.2. Beschwerderecht<br /> Sie haben das Recht, sich bei einer Aufsichtsbehörde zu beschweren, wenn Sie der Ansicht sind, dass die Verarbeitung Ihrer personenbezogenen Daten gegen die DSGVO verstößt.<br /> <br /> Die zuständige Aufsichtsbehörde für uns ist die Landesbeauftragte für Datenschutz und Informationsfreiheit Nordrhein-Westfalen (LDI NRW).<br /> <br /> 6.Datensicherheit<br /> <br /> Wir verwenden innerhalb des Website-Besuchs das verbreitete SSL-Verfahren (Secure Socket Layer) in Verbindung mit der jeweils höchsten Verschlüsselungsstufe, die von Ihrem Browser unterstützt wird. Sie erkennen dies in der Regel an einer geschlossenen Darstellung des Schüssel- bzw. Schloss-Symbols in Ihrer Browserleiste.<br /> <br /> ---<br /> <br /> Privacy Policy for glossary.i-hts.org<br /> <br /> Status: December 16, 2025<br /> <br /> 1.Controller<br /> <br /> The Controller responsible for the processing of personal data within the meaning of the General Data Protection Regulation (GDPR) and other national data protection laws of the member states, as well as other data protection provisions, is:<br /> <br /> EuroScan international network e.V.<br /> (Association registered in Cologne, Germany)<br /> Email: **office@i-hts.org**<br /> Website: glossary.i-hts.org<br /> <br /> 2.Scope of Application<br /> <br /> This Privacy Policy applies to the information offered under the domain glossary.i-hts.org.<br /> <br /> 3.Data Collection and Processing when Visiting the Website<br /> <br /> 3.1. Server Log Files<br /> When merely visiting the website, the browser used on your device automatically sends information to the website server, which is temporarily stored in so-called Server Log Files. This information includes:<br /> <br /> * Browser type and browser version<br /> * Operating system used<br /> * Referrer URL (the previously visited page)<br /> * Hostname of the accessing computer (IP address)<br /> * Time of the server request<br /> <br /> This data is used to ensure a smooth connection setup and comfortable use of our website. The legal basis for processing is Art. 6 para. 1 lit. f GDPR (legitimate interest in the technical functionality of the website).<br /> <br /> 3.2. Cookies<br /> Our MediaWiki installation uses Cookies. These are small text files that are stored on your device. We use temporary (session) cookies to facilitate navigation and ensure security. These cookies are automatically deleted after the end of your visit.<br /> <br /> Legal basis: Art. 6 para. 1 lit. f GDPR.<br /> <br /> 4.Data Processing upon Registration (Personal Data)<br /> <br /> 4.1. Type and Purpose of Data<br /> To be able to act as an author or editor on glossary.i-hts.org, registration is required. Within the scope of this registration, we store the following personal data (mandatory information):<br /> <br /> Username (publicly visible)<br /> Email address (not publicly visible, used for communication and password recovery)<br /> Password (encrypted)<br /> <br /> The purpose of storing this data is the authentication and authorization of users to contribute to the Wiki, and to ensure the traceability of edits (Art. 6 para. 1 lit. b GDPR, performance of the user contract).<br /> <br /> 4.2. Traceability of Contributions<br /> All edits and contributions made by registered users (including the IP address at the time of editing) are permanently stored and are publicly visible under the used Username in the revision history of the respective page. This serves the purpose of transparency and quality assurance.<br /> <br /> 5.Your Rights as a Data Subject<br /> <br /> You have the right to access, rectification, erasure (right to be forgotten), restriction of processing, objection to processing, and data portability.<br /> <br /> 5.1. Access and Erasure (Data Subject Rights)<br /> Since the technical possibilities for direct user management on this MediaWiki instance are limited, we kindly ask you to direct all inquiries regarding your data subject rights (especially **access** to your stored data and the **erasure** of your account and the associated personal data) **exclusively** to our secretariat:<br /> <br /> Email: office@i-hts.org<br /> <br /> The secretariat will process your request and initiate the necessary steps to fulfill your rights.<br /> <br /> Attention: Account erasure is carried out by the secretariat. Contributions you made before deletion will remain in the page history but will be anonymized or attributed to a neutral username where technically and legally possible.<br /> <br /> 5.2. Right to Lodge a Complaint<br /> You have the right to lodge a complaint with a supervisory authority if you believe that the processing of your personal data violates the GDPR.<br /> <br /> The competent supervisory authority for us is the State Commissioner for Data Protection and Freedom of Information North Rhine-Westphalia (LDI NRW).<br /> <br /> 6. Data Security<br /> <br /> During your visit to the website, we use the widespread **SSL procedure** (Secure Socket Layer) in conjunction with the highest level of encryption supported by your browser. You can usually recognize this by a closed key or lock symbol in your browser bar.<br /> <br /> <br /> <strong> Legal statement (in German): </strong><br /> <br /> Information gemäß § 36 VSBG:<br /> <br /> Gemäß § 36 VSBG (Verbraucherstreitbeilegungsgesetz – Gesetz über die alternative Streitbeilegung in Verbrauchersachen) erklärt der Betreiber dieser Website:<br /> <br /> Wir sind bereit, an Streitbeilegungsverfahren bei der folgenden Verbraucherschlichtungsstelle teilzunehmen:<br /> Anwaltliche Verbraucherschlichtungsstelle NRW e.V.<br /> Oberlandesgericht Köln<br /> 3. Etage, Zimmer 316<br /> Reichenspergerplatz 1<br /> 50670 Köln</div>

Admin1 http://glossary.i-hts.org/index.php?title=Regulatory_sandbox&diff=941 Regulatory sandbox 2025-11-18T21:12:05Z

<p>Admin1: /* Existing Cross-sector Definitions */</p> <hr /> <div>A '''regulatory sandbox''' (RS) is a controlled testing environment that allows innovators and regulators to trial new products, services, technologies, or processes under defined conditions. The purpose is to reduce regulatory uncertainty, generate real-world evidence, and inform the development, adaptation, or administration of regulatory frameworks. Regulatory sandboxes are used across multiple sectors worldwide, including finance, energy, mobility, digital services, artificial intelligence, data governance, and increasingly the health sector. Because they emerged in different industries and jurisdictions, multiple definitions coexist, each shaped by specific regulatory cultures, policy goals, and stakeholder needs.[https://artificialintelligenceact.eu/ai-regulatory-sandbox-approaches-eu-member-state-overview/]<br /> <br /> == '''Concept''' ==<br /> Regulatory sandboxes typically include three core elements:<br /> <br /> # A time-limited and scope-limited test environment where innovations can be trialed under supervision.<br /> # Close interaction between innovators, regulators, and other relevant stakeholders throughout the testing period.<br /> # Evidence generation to support future regulatory decisions, risk management, or rulemaking.<br /> <br /> In contrast to general regulatory experimentation, sandboxes are explicitly designed as tools for practical learning, policy development, and implementation-oriented evaluation.[https://digitalfinance.worldbank.org/sites/default/files/2022-11/How-to-Build-a-Regulatory-Sandbox-A-Practical-Guide-for-Policy-Makers.pdf]<br /> <br /> == '''Different Definitions and Contexts''' ==<br /> <br /> === '''Sectoral Variation''' ===<br /> The concept originated in the financial sector, particularly within FinTech innovation (e.g., the UK Financial Conduct Authority in 2015).[https://www.fca.org.uk/firms/innovation/regulatory-sandbox] It has since been adopted in various sectors:<br /> <br /> * Energy systems (e.g., smart grids, decentralized markets) [https://energy.ec.europa.eu/publications/regulatory-sandboxes-energy-sector_en]<br /> * Telecommunications and digital platforms [https://digitalregulation.org/a-case-for-ict-regulatory-sandbox/]<br /> * Mobility and autonomous vehicles [https://www.bundeswirtschaftsministerium.de/Redaktion/EN/Dossier/regulatory-sandboxes.html]<br /> * Artificial intelligence and data ecosystems [https://artificialintelligenceact.eu/article/57/]<br /> * Health Care and medical technologies [https://www.moh.gov.sg/newsroom/moh-launches-first-regulatory-sandbox-to-support-development-of-telemedicine/]<br /> <br /> Each field applies the sandbox model differently. Sector-specific risks, regulatory objectives, and innovation cycles lead to distinct interpretations of what a “sandbox” entails.<br /> <br /> === '''Geographical Variation''' ===<br /> Definitions and implementations vary across regions:<br /> <br /> * Europe: Strong ties to data protection, medical device regulation, and consumer rights; governance-heavy approaches. [https://www.europarl.europa.eu/RegData/etudes/BRIE/2022/733544/EPRS_BRI(2022)733544_EN.pdf]<br /> * North America: More market-driven, often initiated by federal or state-level agencies. [https://www.forbes.com/sites/patrickgleason/2021/12/31/regulatory-sandboxes-give-states-an-edge-attracting-innovation-and-investment/]<br /> * Asia-Pacific: Rapid adoption, frequently focused on AI, digital health, and financial innovation. [https://www.thedatasphere.org/news/sandbox-landscape-in-asia/]<br /> * Africa and Latin America: Sandboxes often support access to services (e.g., digital finance, telemedicine), sometimes in contexts with limited regulatory resources. [https://irff.undp.org/sites/default/files/2024/Nov/insurance-and-telemedicine-in-africa-moonshot_0.pdf]<br /> <br /> === '''Stakeholder Perspectives''' ===<br /> Stakeholders approach regulatory sandboxes with different priorities:<br /> <br /> * Regulators: Evidence generation, risk management, and responsive governance.<br /> * Industry and innovators: Faster testing, reduced compliance burden, accelerated market entry.<br /> * Health Care providers and operators: Real-world implementation testing under safe conditions.<br /> * Public entities and civil society: Emphasis on transparency, safety, ethics, and public value.<br /> <br /> == Existing Cross-sectoral Definitions ==<br /> <br /> ==== Definition by Organisation for Economic Co-operation and Development (OECD) ====<br /> <blockquote>''A regulatory sandbox typically involves a temporary regulatory waiver or flexibility, allowing new products, services, or business models to be tested with fewer regulatory constraints. The purpose of sandboxes is to understand the opportunities and risks associated with specific innovations and to develop an appropriate regulatory environment to accommodate them effectively.[https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/06/regulatory-sandbox-toolkit_cc8d3e50/de36fa62-en.pdf]''</blockquote><br /> <br /> ==== '''Definition by Centre for Regulatory Innovation (CRI)''' ====<br /> The '''Centre for Regulatory Innovation (Canada)''' defines Regulatory Sandboxes as:<blockquote>''A facility, created and controlled by a regulator, designed to allow the conduct of testing or experiments with novel products or processes prior to their full entry into the marketplace.[https://wiki.gccollab.ca/images/6/6b/CRI_Regulators%27_Experimentation_Toolkit.pdf]''</blockquote></div>

Admin1 http://glossary.i-hts.org/index.php?title=Regulatory_sandbox&diff=940 Regulatory sandbox 2025-11-18T21:11:46Z

<p>Admin1: </p> <hr /> <div>A '''regulatory sandbox''' (RS) is a controlled testing environment that allows innovators and regulators to trial new products, services, technologies, or processes under defined conditions. The purpose is to reduce regulatory uncertainty, generate real-world evidence, and inform the development, adaptation, or administration of regulatory frameworks. Regulatory sandboxes are used across multiple sectors worldwide, including finance, energy, mobility, digital services, artificial intelligence, data governance, and increasingly the health sector. Because they emerged in different industries and jurisdictions, multiple definitions coexist, each shaped by specific regulatory cultures, policy goals, and stakeholder needs.[https://artificialintelligenceact.eu/ai-regulatory-sandbox-approaches-eu-member-state-overview/]<br /> <br /> == '''Concept''' ==<br /> Regulatory sandboxes typically include three core elements:<br /> <br /> # A time-limited and scope-limited test environment where innovations can be trialed under supervision.<br /> # Close interaction between innovators, regulators, and other relevant stakeholders throughout the testing period.<br /> # Evidence generation to support future regulatory decisions, risk management, or rulemaking.<br /> <br /> In contrast to general regulatory experimentation, sandboxes are explicitly designed as tools for practical learning, policy development, and implementation-oriented evaluation.[https://digitalfinance.worldbank.org/sites/default/files/2022-11/How-to-Build-a-Regulatory-Sandbox-A-Practical-Guide-for-Policy-Makers.pdf]<br /> <br /> == '''Different Definitions and Contexts''' ==<br /> <br /> === '''Sectoral Variation''' ===<br /> The concept originated in the financial sector, particularly within FinTech innovation (e.g., the UK Financial Conduct Authority in 2015).[https://www.fca.org.uk/firms/innovation/regulatory-sandbox] It has since been adopted in various sectors:<br /> <br /> * Energy systems (e.g., smart grids, decentralized markets) [https://energy.ec.europa.eu/publications/regulatory-sandboxes-energy-sector_en]<br /> * Telecommunications and digital platforms [https://digitalregulation.org/a-case-for-ict-regulatory-sandbox/]<br /> * Mobility and autonomous vehicles [https://www.bundeswirtschaftsministerium.de/Redaktion/EN/Dossier/regulatory-sandboxes.html]<br /> * Artificial intelligence and data ecosystems [https://artificialintelligenceact.eu/article/57/]<br /> * Health Care and medical technologies [https://www.moh.gov.sg/newsroom/moh-launches-first-regulatory-sandbox-to-support-development-of-telemedicine/]<br /> <br /> Each field applies the sandbox model differently. Sector-specific risks, regulatory objectives, and innovation cycles lead to distinct interpretations of what a “sandbox” entails.<br /> <br /> === '''Geographical Variation''' ===<br /> Definitions and implementations vary across regions:<br /> <br /> * Europe: Strong ties to data protection, medical device regulation, and consumer rights; governance-heavy approaches. [https://www.europarl.europa.eu/RegData/etudes/BRIE/2022/733544/EPRS_BRI(2022)733544_EN.pdf]<br /> * North America: More market-driven, often initiated by federal or state-level agencies. [https://www.forbes.com/sites/patrickgleason/2021/12/31/regulatory-sandboxes-give-states-an-edge-attracting-innovation-and-investment/]<br /> * Asia-Pacific: Rapid adoption, frequently focused on AI, digital health, and financial innovation. [https://www.thedatasphere.org/news/sandbox-landscape-in-asia/]<br /> * Africa and Latin America: Sandboxes often support access to services (e.g., digital finance, telemedicine), sometimes in contexts with limited regulatory resources. [https://irff.undp.org/sites/default/files/2024/Nov/insurance-and-telemedicine-in-africa-moonshot_0.pdf]<br /> <br /> === '''Stakeholder Perspectives''' ===<br /> Stakeholders approach regulatory sandboxes with different priorities:<br /> <br /> * Regulators: Evidence generation, risk management, and responsive governance.<br /> * Industry and innovators: Faster testing, reduced compliance burden, accelerated market entry.<br /> * Health Care providers and operators: Real-world implementation testing under safe conditions.<br /> * Public entities and civil society: Emphasis on transparency, safety, ethics, and public value.<br /> <br /> == Existing Cross-sector Definitions ==<br /> <br /> ==== Definition by Organisation for Economic Co-operation and Development (OECD) ====<br /> <blockquote>''A regulatory sandbox typically involves a temporary regulatory waiver or flexibility, allowing new products, services, or business models to be tested with fewer regulatory constraints. The purpose of sandboxes is to understand the opportunities and risks associated with specific innovations and to develop an appropriate regulatory environment to accommodate them effectively.[https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/06/regulatory-sandbox-toolkit_cc8d3e50/de36fa62-en.pdf]''</blockquote><br /> <br /> ==== '''Definition by Centre for Regulatory Innovation (CRI)''' ====<br /> The '''Centre for Regulatory Innovation (Canada)''' defines Regulatory Sandboxes as:<blockquote>''A facility, created and controlled by a regulator, designed to allow the conduct of testing or experiments with novel products or processes prior to their full entry into the marketplace.[https://wiki.gccollab.ca/images/6/6b/CRI_Regulators%27_Experimentation_Toolkit.pdf]''</blockquote></div>

Admin1 http://glossary.i-hts.org/index.php?title=Regulatory_sandbox&diff=939 Regulatory sandbox 2025-11-18T21:11:14Z

<p>Admin1: </p> <hr /> <div>A '''regulatory sandbox''' (RS) is a controlled testing environment that allows innovators and regulators to trial new products, services, technologies, or processes under defined conditions. The purpose is to reduce regulatory uncertainty, generate real-world evidence, and inform the development, adaptation, or administration of regulatory frameworks. Regulatory sandboxes are used across multiple sectors worldwide, including finance, energy, mobility, digital services, artificial intelligence, data governance, and increasingly the health sector. Because they emerged in different industries and jurisdictions, multiple definitions coexist, each shaped by specific regulatory cultures, policy goals, and stakeholder needs.[https://artificialintelligenceact.eu/ai-regulatory-sandbox-approaches-eu-member-state-overview/]<br /> <br /> == '''Concept''' ==<br /> Regulatory sandboxes typically include three core elements:<br /> <br /> # A time-limited and scope-limited test environment where innovations can be trialed under supervision.<br /> # Close interaction between innovators, regulators, and other relevant stakeholders throughout the testing period.<br /> # Evidence generation to support future regulatory decisions, risk management, or rulemaking.<br /> <br /> In contrast to general regulatory experimentation, sandboxes are explicitly designed as tools for practical learning, policy development, and implementation-oriented evaluation.[https://digitalfinance.worldbank.org/sites/default/files/2022-11/How-to-Build-a-Regulatory-Sandbox-A-Practical-Guide-for-Policy-Makers.pdf]<br /> <br /> == '''Different Definitions and Contexts''' ==<br /> <br /> === '''Sectoral Variation''' ===<br /> The concept originated in the financial sector, particularly within FinTech innovation (e.g., the UK Financial Conduct Authority in 2015).[https://www.fca.org.uk/firms/innovation/regulatory-sandbox] It has since been adopted in various sectors:<br /> <br /> * Energy systems (e.g., smart grids, decentralized markets) [https://energy.ec.europa.eu/publications/regulatory-sandboxes-energy-sector_en]<br /> * Telecommunications and digital platforms [https://digitalregulation.org/a-case-for-ict-regulatory-sandbox/]<br /> * Mobility and autonomous vehicles [https://www.bundeswirtschaftsministerium.de/Redaktion/EN/Dossier/regulatory-sandboxes.html]<br /> * Artificial intelligence and data ecosystems [https://artificialintelligenceact.eu/article/57/]<br /> * Health Care and medical technologies [https://www.moh.gov.sg/newsroom/moh-launches-first-regulatory-sandbox-to-support-development-of-telemedicine/]<br /> <br /> Each field applies the sandbox model differently. Sector-specific risks, regulatory objectives, and innovation cycles lead to distinct interpretations of what a “sandbox” entails.<br /> <br /> === '''Geographical Variation''' ===<br /> Definitions and implementations vary across regions:<br /> <br /> * Europe: Strong ties to data protection, medical device regulation, and consumer rights; governance-heavy approaches. [https://www.europarl.europa.eu/RegData/etudes/BRIE/2022/733544/EPRS_BRI(2022)733544_EN.pdf]<br /> * North America: More market-driven, often initiated by federal or state-level agencies. [https://www.forbes.com/sites/patrickgleason/2021/12/31/regulatory-sandboxes-give-states-an-edge-attracting-innovation-and-investment/]<br /> * Asia-Pacific: Rapid adoption, frequently focused on AI, digital health, and financial innovation. [https://www.thedatasphere.org/news/sandbox-landscape-in-asia/]<br /> * Africa and Latin America: Sandboxes often support access to services (e.g., digital finance, telemedicine), sometimes in contexts with limited regulatory resources. [https://irff.undp.org/sites/default/files/2024/Nov/insurance-and-telemedicine-in-africa-moonshot_0.pdf]<br /> <br /> === '''Stakeholder Perspectives''' ===<br /> Stakeholders approach regulatory sandboxes with different priorities:<br /> <br /> * Regulators: Evidence generation, risk management, and responsive governance.<br /> * Industry and innovators: Faster testing, reduced compliance burden, accelerated market entry.<br /> * Health Care providers and operators: Real-world implementation testing under safe conditions.<br /> * Public entities and civil society: Emphasis on transparency, safety, ethics, and public value.<br /> <br /> == Existing Cross-sector Definitions ==<br /> <br /> ==== Definition by Organisation for Economic Co-operation and Development (OECD) ====<br /> <blockquote>''A regulatory sandbox typically involves a temporary regulatory waiver or flexibility, allowing new products, services, or business models to be tested with fewer regulatory constraints. The purpose of sandboxes is to understand the opportunities and risks associated with specific innovations and to develop an appropriate regulatory environment to accommodate them effectively.[https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/06/regulatory-sandbox-toolkit_cc8d3e50/de36fa62-en.pdf]''</blockquote><br /> <br /> ==== '''Definition by Centre for Regulatory Innovation (CRI)''' ====<br /> The '''Centre for Regulatory Innovation (Canada)''' defines Regulatory Sandboxes as:<blockquote>''A facility, created and controlled by a regulator, designed to allow the conduct of testing or experiments with novel products or processes prior to their full entry into the marketplace.[https://wiki.gccollab.ca/images/6/6b/CRI_Regulators%27_Experimentation_Toolkit.pdf]''</blockquote><br /> <br /> == '''Functions and Objectives''' ==<br /> Regulatory sandboxes serve several purposes:<br /> <br /> * Accelerating innovation cycles<br /> * Improving regulatory understanding of emerging technologies<br /> * Generating real-world evidence to support decision-making<br /> * Testing new regulatory approaches<br /> * Enhancing collaboration between regulators and innovators<br /> * Strengthening responsiveness of regulatory systems to disruptive technologies<br /> <br /> ----<br /> <br /> == '''Criticism and Challenges''' ==<br /> Key challenges include:<br /> <br /> * Risk of unequal treatment between participants and non-participants<br /> * Limited generalisability of sandbox results<br /> * Balancing innovation support with safety and consumer/patient protection<br /> * High resource demands for regulators<br /> * Need for clear exit strategies and post-sandbox pathways<br /> <br /> ----<br /> <br /> == '''See also''' ==<br /> <br /> * Regulatory experimentation<br /> * Living labs<br /> * Horizon scanning<br /> * Regulatory science<br /> * Pilot testing in public policy</div>

Admin1 http://glossary.i-hts.org/index.php?title=Regulatory_sandbox&diff=938 Regulatory sandbox 2025-11-18T21:08:27Z

<p>Admin1: </p> <hr /> <div>A '''regulatory sandbox''' (RS) is a controlled testing environment that allows innovators and regulators to trial new products, services, technologies, or processes under defined conditions. The purpose is to reduce regulatory uncertainty, generate real-world evidence, and inform the development, adaptation, or administration of regulatory frameworks. Regulatory sandboxes are used across multiple sectors worldwide, including finance, energy, mobility, digital services, artificial intelligence, data governance, and increasingly the health sector. Because they emerged in different industries and jurisdictions, multiple definitions coexist, each shaped by specific regulatory cultures, policy goals, and stakeholder needs.[https://artificialintelligenceact.eu/ai-regulatory-sandbox-approaches-eu-member-state-overview/]<br /> <br /> == '''Concept''' ==<br /> Regulatory sandboxes typically include three core elements:<br /> <br /> # '''A time-limited and scope-limited test environment''' where innovations can be trialed under supervision.<br /> # '''Close interaction between innovators, regulators, and other relevant stakeholders''' throughout the testing period.<br /> # '''Evidence generation''' to support future regulatory decisions, risk management, or rulemaking.<br /> <br /> In contrast to general regulatory experimentation, sandboxes are explicitly designed as tools for '''practical learning''', policy development, and implementation-oriented evaluation.[https://digitalfinance.worldbank.org/sites/default/files/2022-11/How-to-Build-a-Regulatory-Sandbox-A-Practical-Guide-for-Policy-Makers.pdf]<br /> <br /> == '''Different Definitions and Contexts''' ==<br /> <br /> === '''Sectoral Variation''' ===<br /> The concept originated in the '''financial sector''', particularly within FinTech innovation (e.g., the UK Financial Conduct Authority in 2015).[https://www.fca.org.uk/firms/innovation/regulatory-sandbox] It has since been adopted in various sectors:<br /> <br /> * '''Energy systems''' (e.g., smart grids, decentralized markets) [https://energy.ec.europa.eu/publications/regulatory-sandboxes-energy-sector_en]<br /> * '''Telecommunications and digital platforms [https://digitalregulation.org/a-case-for-ict-regulatory-sandbox/]'''<br /> * '''Mobility and autonomous vehicles [https://www.bundeswirtschaftsministerium.de/Redaktion/EN/Dossier/regulatory-sandboxes.html]'''<br /> * '''Artificial intelligence and data ecosystems [https://artificialintelligenceact.eu/article/57/]'''<br /> * '''Health Care and medical technologies [https://www.moh.gov.sg/newsroom/moh-launches-first-regulatory-sandbox-to-support-development-of-telemedicine/]'''<br /> <br /> Each field applies the sandbox model differently. Sector-specific risks, regulatory objectives, and innovation cycles lead to distinct interpretations of what a “sandbox” entails.<br /> <br /> === '''Geographical Variation''' ===<br /> Definitions and implementations vary across regions:<br /> <br /> * '''Europe''': Strong ties to data protection, medical device regulation, and consumer rights; governance-heavy approaches. [https://www.europarl.europa.eu/RegData/etudes/BRIE/2022/733544/EPRS_BRI(2022)733544_EN.pdf]<br /> * '''North America''': More market-driven, often initiated by federal or state-level agencies. [https://www.forbes.com/sites/patrickgleason/2021/12/31/regulatory-sandboxes-give-states-an-edge-attracting-innovation-and-investment/]<br /> * '''Asia-Pacific''': Rapid adoption, frequently focused on AI, digital health, and financial innovation. [https://www.thedatasphere.org/news/sandbox-landscape-in-asia/]<br /> * '''Africa and Latin America''': Sandboxes often support access to services (e.g., digital finance, telemedicine), sometimes in contexts with limited regulatory resources. [https://irff.undp.org/sites/default/files/2024/Nov/insurance-and-telemedicine-in-africa-moonshot_0.pdf]<br /> <br /> === '''Stakeholder Perspectives''' ===<br /> Stakeholders approach regulatory sandboxes with different priorities:<br /> <br /> * '''Regulators''': Evidence generation, risk management, and responsive governance.<br /> * '''Industry and innovators''': Faster testing, reduced compliance burden, accelerated market entry.<br /> * '''Healthcare providers and operators''': Real-world implementation testing under safe conditions.<br /> * '''Public entities and civil society''': Emphasis on transparency, safety, ethics, and public value.<br /> <br /> == Existing Cross-sector Definitions ==<br /> <br /> ==== Definition by Organisation for Economic Co-operation and Development (OECD) ====<br /> <blockquote>''A regulatory sandbox typically involves a temporary regulatory waiver or flexibility, allowing new products, services, or business models to be tested with fewer regulatory constraints. The purpose of sandboxes is to understand the opportunities and risks associated with specific innovations and to develop an appropriate regulatory environment to accommodate them effectively.[https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/06/regulatory-sandbox-toolkit_cc8d3e50/de36fa62-en.pdf]''</blockquote><br /> <br /> ==== '''Definition by Centre for Regulatory Innovation (CRI)''' ====<br /> The '''Centre for Regulatory Innovation (Canada)''' defines Regulatory Sandboxes as:<blockquote>''A facility, created and controlled by a regulator, designed to allow the conduct of testing or experiments with novel products or processes prior to their full entry into the marketplace.[https://wiki.gccollab.ca/images/6/6b/CRI_Regulators%27_Experimentation_Toolkit.pdf]''</blockquote><br /> <br /> == '''Functions and Objectives''' ==<br /> Regulatory sandboxes serve several purposes:<br /> <br /> * Accelerating innovation cycles<br /> * Improving regulatory understanding of emerging technologies<br /> * Generating real-world evidence to support decision-making<br /> * Testing new regulatory approaches<br /> * Enhancing collaboration between regulators and innovators<br /> * Strengthening responsiveness of regulatory systems to disruptive technologies<br /> <br /> ----<br /> <br /> == '''Criticism and Challenges''' ==<br /> Key challenges include:<br /> <br /> * Risk of unequal treatment between participants and non-participants<br /> * Limited generalisability of sandbox results<br /> * Balancing innovation support with safety and consumer/patient protection<br /> * High resource demands for regulators<br /> * Need for clear exit strategies and post-sandbox pathways<br /> <br /> ----<br /> <br /> == '''See also''' ==<br /> <br /> * Regulatory experimentation<br /> * Living labs<br /> * Horizon scanning<br /> * Regulatory science<br /> * Pilot testing in public policy</div>

Admin1 http://glossary.i-hts.org/index.php?title=Regulatory_sandbox&diff=937 Regulatory sandbox 2025-11-18T21:07:33Z

<p>Admin1: </p> <hr /> <div>A '''regulatory sandbox''' (RS) is a controlled testing environment that allows innovators and regulators to trial new products, services, technologies, or processes under defined conditions. The purpose is to reduce regulatory uncertainty, generate real-world evidence, and inform the development, adaptation, or administration of regulatory frameworks. Regulatory sandboxes are used across multiple sectors worldwide, including finance, energy, mobility, digital services, artificial intelligence, data governance, and increasingly the health sector. Because they emerged in different industries and jurisdictions, multiple definitions coexist, each shaped by specific regulatory cultures, policy goals, and stakeholder needs.[https://artificialintelligenceact.eu/ai-regulatory-sandbox-approaches-eu-member-state-overview/]<br /> <br /> == '''Concept''' ==<br /> Regulatory sandboxes typically include three core elements:<br /> <br /> # '''A time-limited and scope-limited test environment''' where innovations can be trialed under supervision.<br /> # '''Close interaction between innovators, regulators, and other relevant stakeholders''' throughout the testing period.<br /> # '''Evidence generation''' to support future regulatory decisions, risk management, or rulemaking.<br /> <br /> In contrast to general regulatory experimentation, sandboxes are explicitly designed as tools for '''practical learning''', policy development, and implementation-oriented evaluation.[https://digitalfinance.worldbank.org/sites/default/files/2022-11/How-to-Build-a-Regulatory-Sandbox-A-Practical-Guide-for-Policy-Makers.pdf]<br /> <br /> == '''Different Definitions and Contexts''' ==<br /> <br /> === '''Sectoral Variation''' ===<br /> The concept originated in the '''financial sector''', particularly within FinTech innovation (e.g., the UK Financial Conduct Authority in 2015).[https://www.fca.org.uk/firms/innovation/regulatory-sandbox] It has since been adopted in various sectors:<br /> <br /> * '''Energy systems''' (e.g., smart grids, decentralized markets) [https://energy.ec.europa.eu/publications/regulatory-sandboxes-energy-sector_en]<br /> * '''Telecommunications and digital platforms [https://digitalregulation.org/a-case-for-ict-regulatory-sandbox/]'''<br /> * '''Mobility and autonomous vehicles [https://www.bundeswirtschaftsministerium.de/Redaktion/EN/Dossier/regulatory-sandboxes.html]'''<br /> * '''Artificial intelligence and data ecosystems [https://artificialintelligenceact.eu/article/57/]'''<br /> * '''Health Care and medical technologies [https://www.moh.gov.sg/newsroom/moh-launches-first-regulatory-sandbox-to-support-development-of-telemedicine/]'''<br /> <br /> Each field applies the sandbox model differently. Sector-specific risks, regulatory objectives, and innovation cycles lead to distinct interpretations of what a “sandbox” entails.<br /> <br /> === '''Geographical Variation''' ===<br /> Definitions and implementations vary across regions:<br /> <br /> * '''Europe''': Strong ties to data protection, medical device regulation, and consumer rights; governance-heavy approaches. [https://www.europarl.europa.eu/RegData/etudes/BRIE/2022/733544/EPRS_BRI(2022)733544_EN.pdf]<br /> * '''North America''': More market-driven, often initiated by federal or state-level agencies. [https://www.forbes.com/sites/patrickgleason/2021/12/31/regulatory-sandboxes-give-states-an-edge-attracting-innovation-and-investment/]<br /> * '''Asia-Pacific''': Rapid adoption, frequently focused on AI, digital health, and financial innovation. [https://www.thedatasphere.org/news/sandbox-landscape-in-asia/]<br /> * '''Africa and Latin America''': Sandboxes often support access to services (e.g., digital finance, telemedicine), sometimes in contexts with limited regulatory resources. [https://irff.undp.org/sites/default/files/2024/Nov/insurance-and-telemedicine-in-africa-moonshot_0.pdf]<br /> <br /> === '''Stakeholder Perspectives''' ===<br /> Stakeholders approach regulatory sandboxes with different priorities:<br /> <br /> * '''Regulators''': Evidence generation, risk management, and responsive governance.<br /> * '''Industry and innovators''': Faster testing, reduced compliance burden, accelerated market entry.<br /> * '''Healthcare providers and operators''': Real-world implementation testing under safe conditions.<br /> * '''Public entities and civil society''': Emphasis on transparency, safety, ethics, and public value.<br /> <br /> == Existing Cross-sector Definitions ==<br /> <br /> ==== Definition by Organisation for Economic Co-operation and Development (OECD) ====<br /> <blockquote>''A regulatory sandbox typically involves a temporary regulatory waiver or flexibility, allowing new products, services, or business models to be tested with fewer regulatory constraints. The purpose of sandboxes is to understand the opportunities and risks associated with specific innovations and to develop an appropriate regulatory environment to accommodate them effectively.[https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/06/regulatory-sandbox-toolkit_cc8d3e50/de36fa62-en.pdf]''</blockquote><br /> <br /> ==== '''Definition by Centre for Regulatory Innovation (CRI)''' ====<br /> The '''Centre for Regulatory Innovation (Canada)''' defines Regulatory Sandboxes as:<blockquote>''A facility, created and controlled by a regulator, designed to allow the conduct of testing or experiments with novel products or processes prior to their full entry into the marketplace.[https://wiki.gccollab.ca/images/6/6b/CRI_Regulators%27_Experimentation_Toolkit.pdf]''</blockquote><br /> <br /> == '''Functions and Objectives''' ==<br /> Regulatory sandboxes serve several purposes:<br /> <br /> * Accelerating innovation cycles<br /> * Improving regulatory understanding of emerging technologies<br /> * Generating real-world evidence to support decision-making<br /> * Testing new regulatory approaches<br /> * Enhancing collaboration between regulators and innovators<br /> * Strengthening responsiveness of regulatory systems to disruptive technologies<br /> <br /> ----<br /> <br /> == '''Criticism and Challenges''' ==<br /> Key challenges include:<br /> <br /> * Risk of unequal treatment between participants and non-participants<br /> * Limited generalisability of sandbox results<br /> * Balancing innovation support with safety and consumer/patient protection<br /> * High resource demands for regulators<br /> * Need for clear exit strategies and post-sandbox pathways<br /> <br /> ----<br /> <br /> == '''See also''' ==<br /> <br /> * Regulatory experimentation<br /> * Living labs<br /> * Horizon scanning<br /> * Regulatory science<br /> * Pilot testing in public policy<br /> <br /> == References ==</div>

Admin1 http://glossary.i-hts.org/index.php?title=Regulatory_sandbox&diff=936 Regulatory sandbox 2025-11-18T21:00:26Z

<p>Admin1: </p> <hr /> <div>A '''regulatory sandbox''' (RS) is a controlled testing environment that allows innovators and regulators to trial new products, services, technologies, or processes under defined conditions. The purpose is to reduce regulatory uncertainty, generate real-world evidence, and inform the development, adaptation, or administration of regulatory frameworks. Regulatory sandboxes are used across multiple sectors worldwide, including finance, energy, mobility, digital services, artificial intelligence, data governance, and increasingly the health sector. Because they emerged in different industries and jurisdictions, multiple definitions coexist, each shaped by specific regulatory cultures, policy goals, and stakeholder needs.[https://artificialintelligenceact.eu/ai-regulatory-sandbox-approaches-eu-member-state-overview/]<br /> <br /> == '''Concept''' ==<br /> Regulatory sandboxes typically include three core elements:<br /> <br /> # '''A time-limited and scope-limited test environment''' where innovations can be trialed under supervision.<br /> # '''Close interaction between innovators, regulators, and other relevant stakeholders''' throughout the testing period.<br /> # '''Evidence generation''' to support future regulatory decisions, risk management, or rulemaking.<br /> <br /> In contrast to general regulatory experimentation, sandboxes are explicitly designed as tools for '''practical learning''', policy development, and implementation-oriented evaluation.[https://digitalfinance.worldbank.org/sites/default/files/2022-11/How-to-Build-a-Regulatory-Sandbox-A-Practical-Guide-for-Policy-Makers.pdf]<br /> <br /> == '''Different Definitions and Contexts''' ==<br /> <br /> === '''Sectoral Variation''' ===<br /> The concept originated in the '''financial sector''', particularly within FinTech innovation (e.g., the UK Financial Conduct Authority in 2015).[https://www.fca.org.uk/firms/innovation/regulatory-sandbox] It has since been adopted in various sectors:<br /> <br /> * '''Energy systems''' (e.g., smart grids, decentralized markets) [https://energy.ec.europa.eu/publications/regulatory-sandboxes-energy-sector_en]<br /> * '''Telecommunications and digital platforms [https://digitalregulation.org/a-case-for-ict-regulatory-sandbox/]'''<br /> * '''Mobility and autonomous vehicles [https://www.bundeswirtschaftsministerium.de/Redaktion/EN/Dossier/regulatory-sandboxes.html]'''<br /> * '''Artificial intelligence and data ecosystems [https://artificialintelligenceact.eu/article/57/]'''<br /> * '''Health Care and medical technologies [https://www.moh.gov.sg/newsroom/moh-launches-first-regulatory-sandbox-to-support-development-of-telemedicine/]'''<br /> <br /> Each field applies the sandbox model differently. Sector-specific risks, regulatory objectives, and innovation cycles lead to distinct interpretations of what a “sandbox” entails.<br /> <br /> === '''Geographical Variation''' ===<br /> Definitions and implementations vary across regions:<br /> <br /> * '''Europe''': Strong ties to data protection, medical device regulation, and consumer rights; governance-heavy approaches. [https://www.europarl.europa.eu/RegData/etudes/BRIE/2022/733544/EPRS_BRI(2022)733544_EN.pdf]<br /> * '''North America''': More market-driven, often initiated by federal or state-level agencies. [https://www.forbes.com/sites/patrickgleason/2021/12/31/regulatory-sandboxes-give-states-an-edge-attracting-innovation-and-investment/]<br /> * '''Asia-Pacific''': Rapid adoption, frequently focused on AI, digital health, and financial innovation. [https://www.thedatasphere.org/news/sandbox-landscape-in-asia/]<br /> * '''Africa and Latin America''': Sandboxes often support access to services (e.g., digital finance, telemedicine), sometimes in contexts with limited regulatory resources. [https://irff.undp.org/sites/default/files/2024/Nov/insurance-and-telemedicine-in-africa-moonshot_0.pdf]<br /> <br /> === '''Stakeholder Perspectives''' ===<br /> Stakeholders approach regulatory sandboxes with different priorities:<br /> <br /> * '''Regulators''': Evidence generation, risk management, and responsive governance.<br /> * '''Industry and innovators''': Faster testing, reduced compliance burden, accelerated market entry.<br /> * '''Healthcare providers and operators''': Real-world implementation testing under safe conditions.<br /> * '''Public entities and civil society''': Emphasis on transparency, safety, ethics, and public value.<br /> <br /> == Existing Cross-sector Definitions ==<br /> <br /> ==== Definition by Organisation for Economic Co-operation and Development (OECD) ====<br /> <blockquote>''A regulatory sandbox typically involves a temporary regulatory waiver or flexibility, allowing new products, services, or business models to be tested with fewer regulatory constraints. The purpose of sandboxes is to understand the opportunities and risks associated with specific innovations and to develop an appropriate regulatory environment to accommodate them effectively.[https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/06/regulatory-sandbox-toolkit_cc8d3e50/de36fa62-en.pdf]''</blockquote><br /> <br /> ==== '''Definition by Centre for Regulatory Innovation (CRI)''' ====<br /> The '''Centre for Regulatory Innovation (Canada)''' defines Regulatory Sandboxes as:<blockquote>''A facility, created and controlled by a regulator, designed to allow the conduct of testing or experiments with novel products or processes prior to their full entry into the marketplace.[https://wiki.gccollab.ca/images/6/6b/CRI_Regulators%27_Experimentation_Toolkit.pdf]''</blockquote><br /> <br /> == '''Functions and Objectives''' ==<br /> Regulatory sandboxes serve several purposes:<br /> <br /> * Accelerating innovation cycles<br /> * Improving regulatory understanding of emerging technologies<br /> * Generating real-world evidence to support decision-making<br /> * Testing new regulatory approaches<br /> * Enhancing collaboration between regulators and innovators<br /> * Strengthening responsiveness of regulatory systems to disruptive technologies<br /> <br /> ----<br /> <br /> == '''Criticism and Challenges''' ==<br /> Key challenges include:<br /> <br /> * Risk of unequal treatment between participants and non-participants<br /> * Limited generalisability of sandbox results<br /> * Balancing innovation support with safety and consumer/patient protection<br /> * High resource demands for regulators<br /> * Need for clear exit strategies and post-sandbox pathways<br /> <br /> ----<br /> <br /> == '''See also''' ==<br /> <br /> * Regulatory experimentation<br /> * Living labs<br /> * Horizon scanning<br /> * Regulatory science<br /> * Pilot testing in public policy</div>

Admin1 http://glossary.i-hts.org/index.php?title=Regulatory_sandbox&diff=935 Regulatory sandbox 2025-11-18T20:51:00Z

<p>Admin1: Created page with "A '''regulatory sandbox''' (RS) is a controlled testing environment that allows innovators and regulators to trial new products, services, technologies, or processes under defined conditions. The purpose is to reduce regulatory uncertainty, generate real-world evidence, and inform the development, adaptation, or administration of regulatory frameworks. Regulatory sandboxes are used across multiple sectors worldwide, including finance, energy, mobility, digital services,..."</p> <hr /> <div>A '''regulatory sandbox''' (RS) is a controlled testing environment that allows innovators and regulators to trial new products, services, technologies, or processes under defined conditions. The purpose is to reduce regulatory uncertainty, generate real-world evidence, and inform the development, adaptation, or administration of regulatory frameworks. Regulatory sandboxes are used across multiple sectors worldwide, including finance, energy, mobility, digital services, artificial intelligence, data governance, and increasingly the health sector. Because they emerged in different industries and jurisdictions, multiple definitions coexist, each shaped by specific regulatory cultures, policy goals, and stakeholder needs.[https://artificialintelligenceact.eu/ai-regulatory-sandbox-approaches-eu-member-state-overview/]<br /> <br /> == '''Concept''' ==<br /> Regulatory sandboxes typically include three core elements:<br /> <br /> # '''A time-limited and scope-limited test environment''' where innovations can be trialed under supervision.<br /> # '''Close interaction between innovators, regulators, and other relevant stakeholders''' throughout the testing period.<br /> # '''Evidence generation''' to support future regulatory decisions, risk management, or rulemaking.<br /> <br /> In contrast to general regulatory experimentation, sandboxes are explicitly designed as tools for '''practical learning''', policy development, and implementation-oriented evaluation.[https://digitalfinance.worldbank.org/sites/default/files/2022-11/How-to-Build-a-Regulatory-Sandbox-A-Practical-Guide-for-Policy-Makers.pdf]<br /> <br /> == '''Different Definitions and Contexts''' ==<br /> <br /> === '''Sectoral Variation''' ===<br /> The concept originated in the '''financial sector''', particularly within FinTech innovation (e.g., the UK Financial Conduct Authority in 2015).[https://www.fca.org.uk/firms/innovation/regulatory-sandbox] It has since been adopted in various sectors:<br /> <br /> * '''Energy systems''' (e.g., smart grids, decentralized markets) [https://energy.ec.europa.eu/publications/regulatory-sandboxes-energy-sector_en]<br /> * '''Telecommunications and digital platforms [https://digitalregulation.org/a-case-for-ict-regulatory-sandbox/]'''<br /> * '''Mobility and autonomous vehicles [https://www.bundeswirtschaftsministerium.de/Redaktion/EN/Dossier/regulatory-sandboxes.html]'''<br /> * '''Artificial intelligence and data ecosystems [https://artificialintelligenceact.eu/article/57/]'''<br /> * '''Healthcare and medical technologies [https://www.moh.gov.sg/newsroom/moh-launches-first-regulatory-sandbox-to-support-development-of-telemedicine/]'''<br /> <br /> Each field applies the sandbox model differently. Sector-specific risks, regulatory objectives, and innovation cycles lead to distinct interpretations of what a “sandbox” entails.<br /> <br /> === '''Geographical Variation''' ===<br /> Definitions and implementations vary across regions:<br /> <br /> * '''Europe''': Strong ties to data protection, medical device regulation, and consumer rights; governance-heavy approaches.<br /> * '''North America''': More market-driven, often initiated by federal or state-level agencies.<br /> * '''Asia-Pacific''': Rapid adoption, frequently focused on AI, digital health, and financial innovation.<br /> * '''Africa and Latin America''': Sandboxes often support access to services (e.g., digital finance, telemedicine), sometimes in contexts with limited regulatory resources.<br /> <br /> As a result, no single universal definition exists; regional interpretations coexist and remain valid simultaneously.<br /> <br /> === '''Stakeholder Perspectives''' ===<br /> Stakeholders approach regulatory sandboxes with different priorities:<br /> <br /> * '''Regulators''': Evidence generation, risk management, and responsive governance.<br /> * '''Industry and innovators''': Faster testing, reduced compliance burden, accelerated market entry.<br /> * '''Healthcare providers and operators''': Real-world implementation testing under safe conditions.<br /> * '''Public entities and civil society''': Emphasis on transparency, safety, ethics, and public value.<br /> <br /> These varying perspectives contribute to differing definitions, aims, and governance models across sectors.<br /> <br /> == Existing Cross-sector Definitions ==<br /> <br /> ==== Definition by Organisation for Economic Co-operation and Development (OECD) ====<br /> <blockquote>A regulatory sandbox typically involves a temporary regulatory waiver or flexibility, allowing new products, services, or business models to be tested with fewer regulatory constraints. The purpose of sandboxes is to understand the opportunities and risks associated with specific innovations and to develop an appropriate regulatory environment to accommodate them effectively.[https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/06/regulatory-sandbox-toolkit_cc8d3e50/de36fa62-en.pdf]</blockquote><br /> <br /> ==== '''Definition by Centre for Regulatory Innovation (CRI)''' ====<br /> The '''Centre for Regulatory Innovation (Canada)''' defines Regulatory Sandboxes as:<blockquote>''A facility, created and controlled by a regulator, designed to allow the conduct of testing or experiments with novel products or processes prior to their full entry into the marketplace.[https://wiki.gccollab.ca/images/6/6b/CRI_Regulators%27_Experimentation_Toolkit.pdf]''</blockquote><br /> <br /> == '''Regulatory Sandboxes in Healthcare''' ==<br /> In the health sector, regulatory sandboxes are increasingly used to test digital health applications, medical devices, biotechnology innovations, data-driven diagnostics, and AI systems. Health-related sandboxes often place stronger emphasis on safety, privacy, interoperability, and ethical considerations than those in other sectors.<blockquote>xxx</blockquote><br /> <br /> == '''Functions and Objectives''' ==<br /> Regulatory sandboxes serve several purposes:<br /> <br /> * Accelerating innovation cycles<br /> * Improving regulatory understanding of emerging technologies<br /> * Generating real-world evidence to support decision-making<br /> * Testing new regulatory approaches<br /> * Enhancing collaboration between regulators and innovators<br /> * Strengthening responsiveness of regulatory systems to disruptive technologies<br /> <br /> ----<br /> <br /> == '''Criticism and Challenges''' ==<br /> Key challenges include:<br /> <br /> * Risk of unequal treatment between participants and non-participants<br /> * Limited generalisability of sandbox results<br /> * Balancing innovation support with safety and consumer/patient protection<br /> * High resource demands for regulators<br /> * Need for clear exit strategies and post-sandbox pathways<br /> <br /> ----<br /> <br /> == '''See also''' ==<br /> <br /> * Regulatory experimentation<br /> * Living labs<br /> * Horizon scanning<br /> * Regulatory science<br /> * Pilot testing in public policy</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=933 Welcome 2025-08-09T07:05:39Z

<p>Admin1: </p> <hr /> <div>= Welcome to the glossary and wiki for terminologies in life-cycle of health technologies =<br /> <br /> == Topics ==<br /> <br /> * terms, concepts and terminologies used in the health arena for innovations, demands, research, developments, appropriate usage and disinvestment.<br /> * tools and their description in the area of Early Awareness / Re-Assessment (including the process of Horizon Scanning / Disinvestment), Health Technology Assessment (HTA) and Health for all policies (HFAP) including Needs and Demands<br /> <br /> == Resources ==<br /> We are searching and integrating not only the opinion of our own network but include also freely available terms of other global networks and specialised organisations.<br /> <br /> == Participate ==<br /> Be part of the community and join discussions, or even more, be part of the editors community to validate and publish terms<br /> <br /> <big>Register or get in touch with our office: [mailto:Office@i-hts.org office@i-hts.org]</big><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:EuroScan Familie.png|center|thumb|600x600px]]<br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=File:ES_family.png&diff=932 File:ES family.png 2025-08-09T07:03:39Z

<p>Admin1: </p> <hr /> <div>The EuroScan family<br /> <br /> [[File:EuroScan Familie.png|alt=The EuroScan brands and entities|center|thumb|600x600px|The picture is describing the different brands and entities being part of EuroScan]]</div>

Admin1 http://glossary.i-hts.org/index.php?title=File:EuroScan_Familie.png&diff=931 File:EuroScan Familie.png 2025-08-09T07:01:46Z

<p>Admin1: </p> <hr /> <div>all the actual entities/brands of EuroScan</div>

Admin1 http://glossary.i-hts.org/index.php?title=Main_Page&diff=930 Main Page 2025-07-30T10:18:33Z

<p>Admin1: Admin1 moved page Main Page to Welcome</p> <hr /> <div>#REDIRECT [[Welcome]]</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=929 Welcome 2025-07-30T10:18:33Z

<p>Admin1: Admin1 moved page Main Page to Welcome</p> <hr /> <div>= Welcome to the glossary and wiki for terminologies in life-cycle of health technologies =<br /> <br /> == Topics ==<br /> <br /> * terms, concepts and terminologies used in the health arena for innovations, demands, research, developments, appropriate usage and disinvestment.<br /> * tools and their description in the area of Early Awareness / Re-Assessment (including the process of Horizon Scanning / Disinvestment), Health Technology Assessment (HTA) and Health for all policies (HFAP) including Needs and Demands<br /> <br /> == Resources ==<br /> We are searching and integrating not only the opinion of our own network but include also freely available terms of other global networks and specialised organisations.<br /> <br /> == Participate ==<br /> Be part of the community and join discussions, or even more, be part of the editors community to validate and publish terms<br /> <br /> <big>Register or get in touch with our office: [mailto:Office@i-hts.org office@i-hts.org]</big><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:ES family.png|center|thumb|500x500px]]<br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=928 Welcome 2025-07-30T10:17:07Z

<p>Admin1: </p> <hr /> <div>= Welcome to the glossary and wiki for terminologies in life-cycle of health technologies =<br /> <br /> == Topics ==<br /> <br /> * terms, concepts and terminologies used in the health arena for innovations, demands, research, developments, appropriate usage and disinvestment.<br /> * tools and their description in the area of Early Awareness / Re-Assessment (including the process of Horizon Scanning / Disinvestment), Health Technology Assessment (HTA) and Health for all policies (HFAP) including Needs and Demands<br /> <br /> == Resources ==<br /> We are searching and integrating not only the opinion of our own network but include also freely available terms of other global networks and specialised organisations.<br /> <br /> == Participate ==<br /> Be part of the community and join discussions, or even more, be part of the editors community to validate and publish terms<br /> <br /> <big>Register or get in touch with our office: [mailto:Office@i-hts.org office@i-hts.org]</big><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:ES family.png|center|thumb|500x500px]]<br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Welcome&diff=927 Welcome 2025-07-30T10:16:10Z

<p>Admin1: </p> <hr /> <div>= Welcome to the glossary and wiki for terminologies in life-cycle of health technologies =<br /> <br /> == Topics ==<br /> <br /> * terms, concepts and terminologies used in the health arena for innovations, demands, research, developments, appropriate usage and disinvestment.<br /> * tools and their description in the area of Early Awareness / Re-Assessment (including the process of Horizon Scanning / Disinvestment), Health Technology Assessment (HTA) and Health for all policies (HFAP) including Needs and Demands<br /> <br /> == Resources ==<br /> We are searching and integrating not only the opinion of our own network but include also freely available terms of other global networks and specialised organisations.<br /> <br /> == Participate ==<br /> Be part of the community and join discussions, or even more, be part of the editors community to validate and publish terms<br /> <br /> <big>Register or get in touch with out office: [mailto:Office@i-hts.org office@i-hts.org]</big><br /> <br /> == EuroScan international network e.V. ==<br /> The umbrella of our international network: [http://iHTS.org EuroScan international network e.V.]<br /> [[File:ES family.png|center|thumb|500x500px]]<br /> == Next steps ==<br /> Further [[Development steps]]<br /> <br /> __INDEX__<br /> __NEWSECTIONLINK__</div>

Admin1 http://glossary.i-hts.org/index.php?title=Fiscal_year&diff=926 Fiscal year 2025-07-30T06:35:36Z

<p>Admin1: </p> <hr /> <div>A period, generally one year, at the end of which an entity proceeds with the closing of its accounts and the establishment of its annual financial statements.<br /> <br /> Abbreviation: [[FY]]<br /> ==Reference==<br /> http://htaglossary.net/FY</div>

Admin1 http://glossary.i-hts.org/index.php?title=Cochrane_library&diff=925 Cochrane library 2025-07-29T08:13:04Z

<p>Admin1: Admin1 moved page Chochrane library to Cochrane library without leaving a redirect</p> <hr /> <div>A collection of databases updated quarterly, designed to provide scientific information and evidence to support decision making in the health field, published on CD-ROM and on the Internet.<br /> <br /> '''Note:''' The Cochrane Library databases are: the [[Cochrane Database of Systematic Reviews (CDSR)|Cochrane Database of Systematic Reviews]], the [[Cochrane Central Register of Controlled Trials (CENTRAL)|Cochrane Central Register of Controlled Trials]], the [[DARE (Database of Abstracts of Reviews of Effects)|Database of Abstracts of Reviews of Effects]], the [[Cochrane Methodology Register (CMR)|Cochrane Methodology Register]], the [[HTA database|Health Technology Assessment database]] and the NHS Economic Evaluation database.<br /> <br /> == Reference ==<br /> http://htaglossary.net/Cochrane-Library</div>

Admin1 http://glossary.i-hts.org/index.php?title=Cluster_randomized_trials&diff=924 Cluster randomized trials 2025-07-29T08:03:11Z

<p>Admin1: Created page with "==Cluster randomized trials== involve randomization of interventions at the level of natural groups or organizations rather than at the level of patients or other individuals. That is, sets of clinics, hospitals, nursing homes, schools, communities, or geographic regions are randomized to receive interventions or comparators. Such designs are used when it is not feasible to randomize individuals or when an intervention is designed to be delivered at a group or social lev..."</p> <hr /> <div>==Cluster randomized trials==<br /> involve randomization of interventions at the level of natural groups or organizations rather than at the level of patients or other individuals. That is, sets of clinics, hospitals, nursing homes, schools, communities, or geographic regions are randomized to receive interventions or comparators. Such designs are used when it is not feasible to randomize individuals or when an intervention is designed to be delivered at a group or social level, such as a workplace-based smoking cessation campaign or a health care financing mechanism. These are also known as group, place, or community randomized trials.<br /> ==Reference==<br /> Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Clinical_practice_guidelines&diff=923 Clinical practice guidelines 2025-07-29T08:01:31Z

<p>Admin1: /* Clinical practice guideline(s) */</p> <hr /> <div>==Clinical practice guideline(s)==<br /> a systematically developed statement to assist practitioner and patient decisions about appropriate health care for one or more specific clinical circumstances. The development of clinical practice guidelines can be considered to be a particular type of HTA; or, it can be considered to be one of the types of policymaking that is informed or supported by HTA. Clinical registry trials are a type of multicenter trial design using existing online registries as an efficient platform to conduct patient assignment to treatment and control groups, maintain case records, and conduct follow-up. Such trials that randomize patient assignment to treatment and control groups are randomized clinical registry trials (see Fröbert 2010).<br /> ==Reference==<br /> see also [[Clinical guideline]]<br /> <br /> Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Clinical_practice_guidelines&diff=922 Clinical practice guidelines 2025-07-29T07:59:22Z

<p>Admin1: Created page with "==Clinical practice guideline(s)== a systematically developed statement to assist practitioner and patient decisions about appropriate health care for one or more specific clinical circumstances. The development of clinical practice guidelines can be considered to be a particular type of HTA; or, it can be considered to be one of the types of policymaking that is informed or supported by HTA. Clinical registry trials are a type of multicenter trial design using existing..."</p> <hr /> <div>==Clinical practice guideline(s)==<br /> a systematically developed statement to assist practitioner and patient decisions about appropriate health care for one or more specific clinical circumstances. The development of clinical practice guidelines can be considered to be a particular type of HTA; or, it can be considered to be one of the types of policymaking that is informed or supported by HTA. Clinical registry trials are a type of multicenter trial design using existing online registries as an efficient platform to conduct patient assignment to treatment and control groups, maintain case records, and conduct follow-up. Such trials that randomize patient assignment to treatment and control groups are randomized clinical registry trials (see Fröbert 2010).<br /> ==Reference==<br /> see also Clinical guideline<br /> Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Case_study&diff=921 Case study 2025-07-29T07:54:44Z

<p>Admin1: Created page with "==Case study== an uncontrolled (prospective or retrospective) observational study involving an intervention and outcome in a single patient. (Also known as a single case report or anecdote.) ==Reference== Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014."</p> <hr /> <div>==Case study==<br /> an uncontrolled (prospective or retrospective) observational study involving an intervention and outcome in a single patient. (Also known as a single case report or anecdote.)<br /> ==Reference==<br /> Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Biomarker_(or_biological_marker)&diff=920 Biomarker (or biological marker) 2025-07-29T07:48:11Z

<p>Admin1: Created page with "==Biomarker (or biological marker)== an objectively measured variable or trait that is used as an indicator of a normal biological process, a disease state, or effect of a treatment. It may be a physiological measurement (height, weight, blood pressure, etc.), blood component or other biochemical assay (red blood cell count, viral load, HbA1c level, etc.), genetic data (presence of a specific genetic mutation), or measurement from an image (coronary artery stenosis, canc..."</p> <hr /> <div>==Biomarker (or biological marker)==<br /> an objectively measured variable or trait that is used as an indicator of a normal biological process, a disease state, or effect of a treatment. It may be a physiological measurement (height, weight, blood pressure, etc.), blood component or other biochemical assay (red blood cell count, viral load, HbA1c level, etc.), genetic data (presence of a specific genetic mutation), or measurement from an image (coronary artery stenosis, cancer metastases, etc.). (See also intermediate endpoint and surrogate endpoint.)<br /> ==Reference==<br /> Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Bayesian_statistics&diff=919 Bayesian statistics 2025-07-29T07:47:14Z

<p>Admin1: Created page with "==Bayesian statistics== a branch of statistics that involves learning from evidence as it accumulates. It is based on Bayes’ Rule (or Bayes’ Theorem), a mathematical equation that expresses how the prior (initial) probability of an event (or the probability that a hypothesis is true or the distribution for an unknown quantity) changes to a posterior (updated) probability given relevant new evidence. For example, in the diagnosis of a condition in an individual patien..."</p> <hr /> <div>==Bayesian statistics==<br /> a branch of statistics that involves learning from evidence as it accumulates. It is based on Bayes’ Rule (or Bayes’ Theorem), a mathematical equation that expresses how the prior (initial) probability of an event (or the probability that a hypothesis is true or the distribution for an unknown quantity) changes to a posterior (updated) probability given relevant new evidence. For example, in the diagnosis of a condition in an individual patient, a prior probability of a diagnosis may be based on the known prevalence of that condition in a relevant population. This can be updated to a posterior probability based on whether the result of a diagnostic test for that condition in that patient is positive or negative.<br /> ==Reference==<br /> Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Bayesian_clinical_trial&diff=918 Bayesian clinical trial 2025-07-29T07:45:46Z

<p>Admin1: Created page with "==Bayesian clinical trial== a type of adaptive clinical trial that allows for assessment of results during the course of the trial and modifying the trial design to arrive at results more efficiently. Such modifications during trials may include, e.g., changing the ratio of randomization to treatment arms to favor what appear to be more effective therapies, adding or eliminating treatment arms, changing enrollee characteristics to focus on patient subgroups that appear t..."</p> <hr /> <div>==Bayesian clinical trial==<br /> a type of adaptive clinical trial that allows for assessment of results during the course of the trial and modifying the trial design to arrive at results more efficiently. Such modifications during trials may include, e.g., changing the ratio of randomization to treatment arms to favor what appear to be more effective therapies, adding or eliminating treatment arms, changing enrollee characteristics to focus on patient subgroups that appear to be better responders, and slowing or stopping enrollment as certainty increases about treatment effects. Bayesian clinical trials are based on Bayesian statistics.<br /> ==Reference==<br /> Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Allocation_concealment&diff=917 Allocation concealment 2025-07-29T07:43:22Z

<p>Admin1: </p> <hr /> <div>==Allocation concealment==<br /> <br /> refers to the process of ensuring that the persons assessing patients for potential entry into a trial, as well as the patients themselves, do not know whether any particular patient will be allocated to an intervention group or control group. This diminishes selection bias by preventing the persons who are managing patient allocation, or the patients, from influencing (intentionally or not) patient assignment to one group or another. Centralized randomization (i.e., managed at one site rather than at each enrollment site) using certain techniques is a preferred method ensuring allocation concealment. (This is distinct from blinding of patients, providers, and others.)<br /> <br /> ==Reference==<br /> see also: concelament of allocation<br /> <br /> Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Allocation_concealment&diff=916 Allocation concealment 2025-07-29T07:42:37Z

<p>Admin1: Created page with "Allocation concealment refers to the process of ensuring that the persons assessing patients for potential entry into a trial, as well as the patients themselves, do not know whether any particular patient will be allocated to an intervention group or control group. This diminishes selection bias by preventing the persons who are managing patient allocation, or the patients, from influencing (intentionally or not) patient assignment to one group or another. Centralized..."</p> <hr /> <div>Allocation concealment<br /> <br /> refers to the process of ensuring that the persons assessing patients for potential entry into a trial, as well as the patients themselves, do not know whether any particular patient will be allocated to an intervention group or control group. This diminishes selection bias by preventing the persons who are managing patient allocation, or the patients, from influencing (intentionally or not) patient assignment to one group or another. Centralized randomization (i.e., managed at one site rather than at each enrollment site) using certain techniques is a preferred method ensuring allocation concealment. (This is distinct from blinding of patients, providers, and others.)<br /> <br /> Reference<br /> see also: concelament of allocation<br /> <br /> Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda,MD: National Library of Medicine (US); 2014.</div>

Admin1 http://glossary.i-hts.org/index.php?title=Fiscal_year&diff=915 Fiscal year 2025-07-28T12:52:15Z

<p>Admin1: </p> <hr /> <div>A period, generally one year, at the end of which an entity proceeds with the closing of its accounts and the establishment of its annual financial statements.<br /> <br /> Abbreviation: [[FY]]</div>

Admin1 http://glossary.i-hts.org/index.php?title=FY&diff=914 FY 2025-07-28T12:51:50Z

<p>Admin1: </p> <hr /> <div>Abbreviation of fiscal year<br /> <br /> see also: [[fiscal year]]<br /> <br /> == Reference ==<br /> http://htaglossary.net/FY</div>

Admin1 http://glossary.i-hts.org/index.php?title=Fiscal_year&diff=913 Fiscal year 2025-07-28T12:50:47Z

<p>Admin1: Created page with "A period, generally one year, at the end of which an entity proceeds with the closing of its accounts and the establishment of its annual financial statements. Abbreviation: FY"</p> <hr /> <div>A period, generally one year, at the end of which an entity proceeds with the closing of its accounts and the establishment of its annual financial statements.<br /> <br /> Abbreviation: FY</div>

Admin1 http://glossary.i-hts.org/index.php?title=MediaWiki:Sidebar&diff=912 MediaWiki:Sidebar 2025-07-28T12:38:15Z

<p>Admin1: </p> <hr /> <div><br /> * navigation<br /> ** mainpage|mainpage-description<br /> ** Special:AllPages|All Terms (A-Z)<br /> ** recentchanges-url|recentchanges<br /> // ** randompage-url|randompage<br /> ** helppage|help-mediawiki<br /> * SEARCH<br /> * TOOLBOX<br /> * LANGUAGES</div>

Admin1 http://glossary.i-hts.org/index.php?title=MediaWiki:Sidebar&diff=911 MediaWiki:Sidebar 2025-07-28T12:37:36Z

<p>Admin1: </p> <hr /> <div><br /> * navigation<br /> ** mainpage|mainpage-description<br /> ** Special:AllPages|All Pages (A-Z)<br /> ** recentchanges-url|recentchanges<br /> // ** randompage-url|randompage<br /> ** helppage|help-mediawiki<br /> * SEARCH<br /> * TOOLBOX<br /> * LANGUAGES</div>

Admin1 http://glossary.i-hts.org/index.php?title=MediaWiki:Sidebar&diff=910 MediaWiki:Sidebar 2025-07-28T12:37:07Z

<p>Admin1: </p> <hr /> <div><br /> * navigation<br /> ** mainpage|mainpage-description<br /> ** Glossary|Special:AllPages|All Pages (A-Z)<br /> ** recentchanges-url|recentchanges<br /> // ** randompage-url|randompage<br /> ** helppage|help-mediawiki<br /> * SEARCH<br /> * TOOLBOX<br /> * LANGUAGES</div>

Admin1 http://glossary.i-hts.org/index.php?title=MediaWiki:Sidebar&diff=909 MediaWiki:Sidebar 2025-07-28T12:32:38Z

<p>Admin1: </p> <hr /> <div><br /> * navigation<br /> ** mainpage|mainpage-description<br /> ** Glossary|AllPages<br /> ** recentchanges-url|recentchanges<br /> // ** randompage-url|randompage<br /> ** helppage|help-mediawiki<br /> * SEARCH<br /> * TOOLBOX<br /> * LANGUAGES</div>

Admin1